The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Acadia Pharmaceuticals Inc | COM | 004225108 | 30,574 | 1,263,930 | SH | OTR | 1,263,930 | 0 | 0 | ||
| Akero Therapeutics Inc | COM | 00973Y108 | 11,799 | 831,495 | SH | OTR | 831,495 | 0 | 0 | ||
| Aligos Therapeutics Inc | COM | 01626L105 | 3,281 | 1,526,048 | SH | OTR | 1,526,048 | 0 | 0 | ||
| Amicus Therapeutics Inc | COM | 03152W109 | 22,018 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | ||
| Amylyx Pharmaceuticals Inc | COM | 03237H101 | 28,270 | 2,200,000 | SH | OTR | 2,200,000 | 0 | 0 | ||
| AnaptysBio Inc | COM | 032724106 | 32,162 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
| Apellis Pharmaceuticals Inc | COM | 03753U106 | 66,241 | 1,303,700 | SH | OTR | 1,303,700 | 0 | 0 | ||
| Arcus Biosciences Inc | COM | 03969F109 | 45,200 | 1,432,200 | SH | OTR | 1,432,200 | 0 | 0 | ||
| Atreca Inc | CL A COM | 04965G109 | 6,981 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | ||
| Avidity Biosciences Inc | COM | 05370A108 | 20,711 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | ||
| BeiGene Ltd | SPONSORED ADR | 07725L102 | 94,300 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Bellicum Pharmaceuticals Inc | COM NEW | 079481404 | 123 | 56,950 | SH | OTR | 56,950 | 0 | 0 | ||
| Bellus Health Inc | COM NEW | 07987C204 | 22,016 | 3,200,000 | SH | OTR | 3,200,000 | 0 | 0 | ||
| BioAtla Inc | COM | 09077B104 | 3,452 | 686,347 | SH | OTR | 686,347 | 0 | 0 | ||
| Biomea Fusion Inc | COM | 09077A106 | 5,300 | 1,188,405 | SH | OTR | 1,188,405 | 0 | 0 | ||
| Black Diamond Therapeutics Inc | COM | 09203E105 | 5,581 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | ||
| BCLS Acquisition Corp | COM CL A | G0904B105 | 4,935 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Blueprint Medicines Corp | COM | 09627Y109 | 32,411 | 507,374 | SH | OTR | 507,374 | 0 | 0 | ||
| Cabaletta Bio Inc | COM | 12674W109 | 1,096 | 540,000 | SH | OTR | 540,000 | 0 | 0 | ||
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 152309100 | 11,273 | 1,251,137 | SH | OTR | 1,251,137 | 0 | 0 | ||
| Codiak Biosciences Inc | COM | 192010106 | 5,330 | 850,065 | SH | OTR | 850,065 | 0 | 0 | ||
| Cullinan Oncology Inc | COM | 230031106 | 11,246 | 1,074,082 | SH | OTR | 1,074,082 | 0 | 0 | ||
| Cytokinetics Inc | COM NEW | 23282W605 | 77,301 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
| Day One Biopharmaceuticals Inc | COM | 23954D109 | 11,804 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | ||
| DBV Technologies SA | SPONSORED ADR | 23306J101 | 3,394 | 2,134,598 | SH | OTR | 2,134,598 | 0 | 0 | ||
| Elevation Oncology Inc | COM | 28623U101 | 2,199 | 872,780 | SH | OTR | 872,780 | 0 | 0 | ||
| EQRX Inc | COM | 26886C107 | 4,130 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
| Essa Pharma Inc | COM NEW | 29668H708 | 4,485 | 724,500 | SH | OTR | 724,500 | 0 | 0 | ||
| Fate Therapeutics Inc | COM | 31189P102 | 19,385 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Gemini Therapeutics Inc | COM | 36870G105 | 1,807 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
| Genocea Biosciences Inc | COM NEW | 372427401 | 1,418 | 1,134,453 | SH | OTR | 1,134,453 | 0 | 0 | ||
| GH Research PLC | ORDINARY SHARES | G3855L106 | 18,535 | 1,013,399 | SH | OTR | 1,013,399 | 0 | 0 | ||
| Gossamer Bio Inc | COM | 38341P102 | 21,373 | 2,462,358 | SH | OTR | 2,462,358 | 0 | 0 | ||
| Health Sciences Acq Corp II | ORD SHS | G4411D109 | 3,964 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
| Ideaya Biosciences Inc | COM | 45166A102 | 24,649 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
| Iovance Biotherapeutics Inc | COM | 462260100 | 32,220 | 1,935,133 | SH | OTR | 1,935,133 | 0 | 0 | ||
| iTeos Therapeutics Inc | COM | 46565G104 | 102,720 | 3,192,058 | SH | OTR | 3,192,058 | 0 | 0 | ||
| Kinnate Biopharma Inc | COM | 49705R105 | 20,804 | 1,847,559 | SH | OTR | 1,847,559 | 0 | 0 | ||
| MEI Pharma Inc | COM NEW | 55279B202 | 1,755 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
| Merus NV | COM | N5749R100 | 50,236 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
| Milestone Pharmaceuticals Inc | COM | 59935V107 | 14,373 | 2,238,861 | SH | OTR | 2,238,861 | 0 | 0 | ||
| Mirati Therapeutics Inc. | COM | 60468T105 | 164,440 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
| Nuvalent Inc | COM | 670703107 | 16,810 | 1,210,192 | SH | OTR | 1,210,192 | 0 | 0 | ||
| NGM Biopharmaceuticals Inc | COM | 62921N105 | 7,625 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| Nurix Therapeutics Inc | COM | 67080M103 | 17,161 | 1,224,892 | SH | OTR | 1,224,892 | 0 | 0 | ||
| Nuvation Bio Inc | COM CL A | 67080N101 | 22,834 | 4,341,009 | SH | OTR | 4,341,009 | 0 | 0 | ||
| Nuvation Bio Inc | *W EXP 07/07/202 | 67080N119 | 203 | 266,666 | SH | OTR | 266,666 | 0 | 0 | ||
| Odonate Therapeutics Inc | COM | 676079106 | 5,553 | 4,207,086 | SH | OTR | 4,207,086 | 0 | 0 | ||
| Omega Alpha SPAC | CL A | G6749V107 | 1,964 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| Oric Pharmaceuticals Inc | COM | 68622P109 | 5,628 | 1,054,000 | SH | OTR | 1,054,000 | 0 | 0 | ||
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | 4,875 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| PMV Pharmaceuticals Inc | COM | 69353Y103 | 72,842 | 3,498,636 | SH | OTR | 3,498,636 | 0 | 0 | ||
| Point Biopharma Global Inc | COM | 730541109 | 19,925 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
| Prometheus Biosciences Inc | COM | 74349U108 | 64,721 | 1,714,000 | SH | OTR | 1,714,000 | 0 | 0 | ||
| Protara Therapeutics Inc | COM STK | 74365U107 | 1,069 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
| Prothena Corp PLC | SHS | G72800108 | 10,971 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
| Rain Therapeutics Inc | COM | 75082Q105 | 5,957 | 1,175,000 | SH | OTR | 1,175,000 | 0 | 0 | ||
| Reata Pharmaceuticals Inc | CL A | 75615P103 | 40,590 | 1,239,000 | SH | OTR | 1,239,000 | 0 | 0 | ||
| Relay Therapeutics Inc | COM | 75943R102 | 79,887 | 2,669,132 | SH | OTR | 2,669,132 | 0 | 0 | ||
| Revolution Medicines Inc | COM | 76155X100 | 88,884 | 3,484,264 | SH | OTR | 3,484,264 | 0 | 0 | ||
| Rocket Pharmaceuticals Inc | COM | 77313F106 | 23,252 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
| Sage Therapeutics Inc | COM | 78667J108 | 36,211 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | ||
| Selecta Biosciences Inc | COM | 816212104 | 4,039 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | ||
| Solid Biosciences Inc | COM | 83422E105 | 6,403 | 5,336,031 | SH | OTR | 5,336,031 | 0 | 0 | ||
| SPDR SER TR | S&P BIOTECH | 78464A870 | 62,916 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
| Springworks Therapeutics Inc | COM | 85205L107 | 117,164 | 2,075,905 | SH | OTR | 2,075,905 | 0 | 0 | ||
| Surrozen Inc | *W EXP 08/01/203 | 86889P117 | 17 | 66,666 | SH | OTR | 66,666 | 0 | 0 | ||
| Tango Therapeutics Inc | COM | 87583X109 | 52,087 | 6,871,642 | SH | OTR | 6,871,642 | 0 | 0 | ||
| Theseus Pharmaceuticals Inc | COM | 88369M101 | 10,285 | 892,057 | SH | OTR | 892,057 | 0 | 0 | ||
| Turning Point Therapeutics Inc | COM | 90041T108 | 10,740 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
| 2Seventy Bio Inc | COMMON STOCK | 901384107 | 7,845 | 459,836 | SH | OTR | 459,836 | 0 | 0 | ||
| Tyra Biosciences Inc | COM | 90240B106 | 68,997 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | ||
| Ultragenyx Pharmaceutical Inc | COM | 90400D108 | 14,524 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| Xenon Pharmaceuticals Inc | COM | 98420N105 | 18,342 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||